CatalYm
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Am Klopferspitz 19, Planegg, Bavaria, 82...Phone Number
+49 89200066440Website
www.catalym.comRevenue
<$5 MillionIndustry
About CatalYm
CatalYm Org Chart
Is CatalYm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at CatalYm
Check if CatalYm has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on CatalYm recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if CatalYm is spiking on competitors!
Funding: Get notified immidiatlly once CatalYm has new funding data
Click to see if CatalYm had a recent Job posting/layoffs
CatalYm, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CatalYm launches new products
Recommended Actions
Find VP level buyers at CatalYm
Find more new buyers
Company Profile Activity
Activity Insights
CatalYm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CatalYm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CatalYm.
CatalYm financials insights
Gather financial insights about CatalYm, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$59M
Series C
$49M
Series D
$150M
CatalYm Tech Stack
A closer look at the technologies used by CatalYm
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CatalYm
CatalYm is a biotechnology company focused on developing innovative immunotherapies to combat cancer by targeting GDF-15, a key mechanism of resistance to cancer therapies. The company aims to enhance immune cell activation and tumor infiltration, thereby reinstating effective responses to checkpoint inhibition. Led by a team of experienced drug de... Read More
